Gladys Antelo-Allen of Camden Coalition discusses a new skills lab offering accessible learning modules with 12 microlessons ...

A looming Supreme Court ruling will answer questions about the legality of the Affordable Care Act mandate for providing some ...

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

Early adult death in the US has significantly increased since 2010, with mortality rates exceeding prepandemic levels, even ...

Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease ...

Private equity hospital acquisitions in the US were associated with declines in patient care experience, particularly in ...

Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to ...

Panelists discuss the most common logistical challenges encountered when implementing bispecific therapies in both academic ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based ...